Lindbrook Capital’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$18.2K Buy
746
+529
+244% +$13.6K ﹤0.01% 1392
2024
Q4
$5.19K Buy
217
+193
+804% +$6.13K ﹤0.01% 1972
2024
Q3
$1.02K Buy
24
+20
+500% +$1.05K ﹤0.01% 2498
2024
Q2
$205 Buy
+4
New +$227 ﹤0.01% 2701
2024
Q1
Sell
-67
Closed -$5.02K 2648
2023
Q4
$5.02K Buy
67
+61
+1,017% +$4.36K ﹤0.01% 1890
2023
Q3
$511 Sell
6
-4
-40% -$379 ﹤0.01% 2532
2023
Q2
$1.09K Buy
+10
New +$948 ﹤0.01% 2354
2023
Q1
Sell
-79
Closed -$8.12K 2776
2022
Q4
$8.12K Sell
79
-64
-45% -$7.37K ﹤0.01% 1539
2022
Q3
$15K Sell
143
-73
-34% -$8K ﹤0.01% 1120
2022
Q2
$24K Buy
216
+8
+4% +$792 ﹤0.01% 903
2022
Q1
$22K Buy
208
+170
+447% +$17.6K ﹤0.01% 962
2021
Q4
$5K Sell
38
-7
-16% -$777 ﹤0.01% 1483
2021
Q3
$5K Buy
45
+6
+15% +$636 ﹤0.01% 1223
2021
Q2
$4K Buy
39
+32
+457% +$2.78K ﹤0.01% 1333
2021
Q1
$1K Buy
+7
New +$520 ﹤0.01% 1661

Other funds holding AMN

Lindbrook Capital's AMN Position: Q1 2025 in Review

Lindbrook Capital increased its AMN Healthcare (AMN) stake by 244% in Q1 2025, buying an estimated $13.6K and bringing the position to 746 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Lindbrook Capital first reported a position in AMN in Q1 2021 and has held it in 15 quarters since. The position peaked at $24K in Q2 2022. 292 funds tracked by Wall St. Rank hold AMN as of Q1 2025.

  • Lindbrook Capital held 746 shares of AMN Healthcare worth $18.2K as of Q1 2025.
  • Lindbrook Capital bought 529 AMN Healthcare shares in Q1 2025, an estimated $13.6K.
  • AMN Healthcare made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1392 holding.
  • Lindbrook Capital first reported a position in AMN Healthcare in Q1 2021 and has held it in 15 quarters since.
  • Lindbrook Capital's AMN Healthcare position peaked at $24K in Q2 2022.
  • 292 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.